Dr. Grewal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114
Summary
- I am a physician-scientist with a primary interest in developing novel immunotherapies to cure cancer. My background is in tumor immunology, with an emphasis on tumor vaccines, T cell-based therapies, dendritic cells, innate immune agonists, and antigen-specific immune responses. I am a card-carrying immunologist, with multiple years of experience working in bench research (manipulating both mouse and human cells for basic research and translational purposes). I am also a translational researcher, having played major roles in multiple phase I/II clinical trials testing experimental immunotherapies in patients with advanced malignancies. I hope to combine my lab skills with clinical insight to provide cures for patients who currently have no definitive options for their cancer.
Education & Training
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 2022 - 2025
Mayo Clinic College of MedicineClass of 2022
Harvard Medical SchoolMaster's, Immunology, 2016 - 2018- University of California, BerkeleyUndergrad, 2014 - 2016
Certifications & Licensure
MA State Medical License 2022 - 2025
Awards, Honors, & Recognition
- Gold Humanism Honor Society 2021
Clinical Trials
- MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2015 Jan 27
- Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma Start of enrollment: 2018 Oct 05
- CARv3-TEAM-E T Cells in Glioblastoma Start of enrollment: 2023 Mar 22
Publications & Presentations
PubMed
- Clinical progress in the development of CAR T cells to treat malignant glioma.Eric P Grewal, Brian V Nahed, Bob S Carter, Elizabeth R Gerstner, William T Curry
Journal of Neuro-Oncology. 2025-02-01 - Severe antigen excess confounding the detection ofvia rapid antigen assay.Eric P Grewal, Eric P Grewal, Anthony R Russo, Maxwell T Roth, Eunice L Rogaishio
Journal of Clinical Pathology. 2024-12-18 - 1 citationsMutant IDH Modulates Suppressive Myeloid Populations in Malignant Glioma.Eric P Grewal, Leland G K Richardson, Jing Sun, Rishab Ramapriyan, Maria Martinez-Lage
Clinical Cancer Research. 2024-09-13
Journal Articles
- Schistosomiasis prevalence and low-cost diagnostics in rural Northwestern Madagascar: a pilot studyRobinson KE, Grewal EP, Pritt BS, et al., Journal of Global Health Reports, 4/19/2021
Grant Support
- Student Research GrantMelanoma Research Foundation2021–2022
Other Languages
- Hindi, Spanish, Punjabi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
